Risk factors, endothelial function, and clinical outcome after coronary bypass surgery Voors, Adriaan

Transcription

1 University of Groningen Risk factors, endothelial function, and clinical outcome after coronary bypass surgery Voors, Adriaan IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 1997 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Voors, A. A. (1997). Risk factors, endothelial function, and clinical outcome after coronary bypass surgery s.n. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date:

2 140 list of publications List of publications Papers Brussel van BL, Plokker HWM, Ernst JMPG, Ernst NM, Knaepen PG, Koomen EM, Tijssen JGP, Vermeulen FEE, Voors AA. Venous coronary artery bypass surgery: a 15- year follow-up study. Circulation 1993;88[part 2]: Voors AA, Kingma JH, Van Gilst WH. Drug differences between ACE-inhibitors in experimental settings and clinical practice. J Cardiovasc Risk 1995;2: Brussel van BL, Plokker HWM, Voors AA, Ernst JMPG, Ernst NM, Knaepen PJ, Koomen EM, Tijssen JGP, Vermeulen FEE. Multivariate Risk Factor Analysis of Clinical Outcome 15 Years After Venous Coronary Artery Bypass Graft Surgery. Eur Heart J 1995;16: Berg ten JM, Suttorp MJ, Jaarsma W, Voors AA, Langemeijer JJM, Knaepen PJ, Ernst JMPG. Hypertrofische, Obstructieve Cardiomyopathie: Resultaten op Korte en Lange Termijn na Septummyectomie volgens Morrow. Cardiologie 1995;2: Voors AA, Brussel van BL, Plokker HWM, Ernst JMPG, Ernst NM, Koomen EM, Tijssen JGP, Vermeulen FEE. Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. Circulation 1996;93:42-7. Berg ten JM, Voors AA, Suttorp MJ, Ernst JMPG, Mast EG, Bal E, Plokker HWM. Long-term results after successful percutaneous transluminal coronary angioplasty in patients over 75 years of age. Am J Cardiol 1996;77: Brussel van BL, Plokker HWM, Voors AA, Ernst JMPG, Kelder JC, Knaepen PJ, Vermeulen FEE. Different clinical outcome in single and sequential venous coronary artery bypass graft surgery: A 15 year follow-up study. J Thorac Cardiovasc Surg 1996;112: Voors AA, Kingma JH, Van Gilst WH. ACE-remmers na een acuut myocardinfarct: bij wie, wanneer starten en met welk middel? Hartbulletin 1996;27:51-6. Grandjean JG, Voors AA, Boonstra PW, Den Heyer PW, Ebels T. Exclusive Use of Arterial Grafts in Revascularization of Three Vessel Disease. Employing both mammary arteries and the gastroepiploic artery in 256 consecutive patients. J Thorac Cardiovasc Surg 1996;112: Voors AA, Brussel van BL, Plokker HWM, Ernst JMPG, Ernst NM, Koomen EM, Tijssen JGP, Vermeulen FEE. Roken en 15 Jaar Klinische Follow-Up na Veneuze Coronaire Bypass Chirurgie. Hartbulletin 1996;27(4):

3 list of publications 141 Voors AA, Van Gilst WH, Kingma JH. Angiotensine II-AT receptor antagonisten: ontwikkeling, toepassing en vergelijking met ACE-remmers. Cardiologie 1996;3: Brussel van BL, Ernst JMPG, Ernst NM, Knaepen PG, Koomen EM, Plokker, HWM, Tijssen JGP, Vermeulen FEE, Voors AA. Clinical outcome in venous coronary artery bypass grafting: a 15-year follow-up study. Int J Cardiol 1997;58: Brussel van BL, Plokker HWM, Voors AA, Ernst JMPG, Kelder JC. Progression of atherosclerosis after venous coronary artery bypass graft surgery: a 15-year follow-up study. Cath Cardiovasc Diagn 1997 [in press]. Voors AA, Brussel van BL, Kelder JC, Plokker HWM. Usefulness of hypertriglyceridemia in predicting myocardial infarction late after coronary bypass operation. Am J Cardiol 1997 [in press]. Voors AA, Oosterga M, Buikema H, May JF, Grandjean JG, Buiten van A, Van Gilst WH. Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery. Cardiovasc Res 1997 [in press]. Abstracts Brussel van BL, Plokker HWM, Ernst JMPG, Hemel van NM, Knaepen PG, Koomen EM, Tijssen JGP, Vermeulen FEE, Voors AA. True long-term (15 year) follow up of patients who underwent venous aorto-coronary bypass grafting (ACBG). Eur Heart J 1993;14(suppl):II-171. Voors AA, Brussel van BL, Plokker HWM, Ernst JMPG, Ernst NM, Knaepen PG, Koomen EM, Tijssen JGP, Vermeulen FEE. Obesity and hypertriglyceridemia turn out to be independent predictors of late myocardial infarction during 15 years follow-up after venous coronary artery bypass grafting. Circulation 1993;88-4[suppl.2]:I-259. Brussel van BL, Plokker HWM, Ernst JMPG, Ernst NM, Knaepen PG, Vermeulen FEE, Koomen EM, Voors AA, Tijssen JGP. Smoking after venous coronary artery bypass grafting has deleterious effects on cardiac event rates. Circulation 1993;88-4[suppl.2]:I Voors AA, Berg ten JM, Plokker HWM, Ernst JMPG, Bal ET, Suttorp MJ, Mast EG. Long term results of PTCA in patients over 75 years of age: a matched control study. J Am Col Cardiol 1994;23:434A. Brussel van BL, Plokker HWM, Ernst JMPG, Ernst NM, Knaepen PG, Vermeulen FEE, Koomen EM, Voors AA, Tijssen JGP. Which postoperative risk-factors can predict mortality and event rates after venous coronary artery bypass grafting? J Am Coll Cardiol 1994;23:347A.

4 142 list of publications Voors AA, Brussel van BL, Plokker HWM, Ernst JMPG, Knaepen PG, Koomen EM, Tijssen JGP, Vermeulen FEE. Smoking cessation and the risk of acute myocardial infarction after venous coronary artery bypass grafting: 15 year follow-up. J Am Coll Cardiol 1994;23:460A. Plokker HWM, Brussel van BL, Ernst JMPG, Knaepen PG, Koomen EM, Voors AA, Tijssen JGP, Vermeulen FEE. Late repeat coronary angiography demonstrates that progression of native coronary artery disease is almost as important as graft attrition after isolated venous aorto coronary bypass grafting. Cathet Cardiovasc Diagnosis 1994;31: Brussel van BL, Plokker HWM, Voors AA, Ernst JMPG, Vermeulen FEE, Knaepen PG, Tijssen JGP. Single versus sequential grafts in venous coronary-bypass surgery: differencesin cardiac event rates after 15 years follow-up. Eur Heart J 1994;15(suppl):28. Brussel van BL, Voors AA, Plokker HWM, Ernst JMPG, Ernst NM, Knaepen PJ, Koomen EM, Tijssen JGP, Vermeulen FEE. Risicofactoren voor mortaliteit en morbiditeit 15 jaar na veneuze aortocoronaire bypass-chirurgie? Ned Tijdschr Geneeskd 1994;138:1596. Voors AA, Van Brussel BL, Plokker HWM, Buikema H, Van Gilst WH, Kingma JH. Dipyramidole increases myocardial infarction rate 15 years after venous coronary bypass surgery. Pharmacy World & Science 1994;16[suppl H];H21. Pinto YM, Voors AA, Buikema H, Grandjean JG, Ebels T, Lie K.I. Van Gilst WH. Will patients with coronary artery disease benefit from inhibition of vascular angiotensinconverting enzyme? Rationale and design of the QUO VADIS study. Atherosclerosis 1995;115 (Suppl):S55. Voors AA, Pinto YM, Buikema H, Grandjean JG, Kingma JH, Van Gilst WH. Inhibition of angiotensin II effects in human arteries: is antagonism of the angiotensin II-AT1 receptor more effective than ACE-inhibition? Atherosclerosis 1995;115:S63. Voors AA, Pinto YM, Buikema H, Grandjean JG, Paul M, Urata H, Kingma JH, Van Gilst WH. Preventing the effects of angiotensin II: ACE-inhibition or angiotensin II- AT1-receptor antagonism? Eur Heart J 1995 (Suppl):453. Voors AA, Pinto YM, Buikema H, Grandjean JG, Paul M, Urata H, Kingma JH, Van Gilst WH. ACE- and Chymase-dependent angiotensin II forming pathways in human internal mammary arteries. J Hypertens 1996;14(Suppl 1):S80. Voors AA, Van Brussel BL, Plokker HWM. Post-operative systolic blood pressure predicts longterm (cardiac) mortality after venous coronary bypass surgery. J Hypertens 1996; 14 (Suppl 1):S247.

5 list of publications 143 Oosterga M, Voors AA, de Kam PJ, Kingma JH, van Gilst WH and the CATS Investigators. Determinants of left ventricular dilation in patients receiving thrombolytic therapy for myocardial infarction: a one-year follow-up. Eur Heart J 1996;17 (abstract supplement):260. Oosterga M, Voors AA, de Kam PJ, van Geel PP, Kingma JH, Schunkert H, van Gilst WH for the CATS Investigators. Plasma angiotensin-converting enzyme activity and left ventricular dilation after myocardial ischemia. Circulation 1996;94 (suppl 1): I-62. Voors AA, Grandjean JG, Boonstra PW, Ebels T. Aprotinin use during coronary bypass surgery is associated with increased risks for myocardial infarction. Circulation 1996;94 (suppl 1): I-62. Voors AA, Oosterga M, Buikema H, Pinto YM, Grandjean JG, Morshuis WJ, Kingma JH, Van Gilst WH. Total serum cholesterol is the best predictor for endothelial dysfunction in internal mammary arteries of coronary bypass patients. J Am Coll Cardiol 1997;29(suppl 2):46A. Oosterga M, Voors AA, De Kam P-J, Peels KH, Kingma JH, Van Gilst WH. Determinants of left ventricular dilation in patients receivingg thrombolytic therapy for myocardial infarction. J Am Coll Cardiol 1997;29(suppl 2):89A. Voors AA, Oosterga M, Buikema H, Pinto YM, Grandjean JG, Van Gilst WH. Dose response relation between cigarette consumption and endothelial function. J Am Coll Cardiol 1997;29(suppl 2):263A.

6

7 DE KOE Een koe is een merkwaardig beest wat er ook in haar geest moge zijn haar laatste woord is altijd boe (K. Schippers)